CONTINUUM: Lifelong Learning in Neurology:
doi: 10.1212/01.CON.0000450965.30710.e9
Review Articles


Tavee, Jinny O. MD; Stern, Barney J. MD, FAAN

Collapse Box


Purpose of Review:: This article provides an update on the evaluation and treatment of neurosarcoidosis.

Recent Findings:: The broad range of clinical manifestations of neurosarcoidosis has recently expanded to include painful small fiber neuropathy. Although definitive diagnosis remains a challenge, fluorodeoxyglucose positron emission tomographic (FDG-PET) scan and high-resolution CT allow for improved detection of systemic sarcoidosis. In addition, endobronchial ultrasound-guided transbronchial needle aspiration provides a less invasive means of tissue confirmation of systemic sarcoidosis than mediastinoscopy. Although not standardized, treatment strategies for neurosarcoidosis now commonly include tumor necrosis factor-α antagonists in combination with corticosteroids and other cytotoxic agents for patients with severe disease.

Summary:: Advances in the diagnosis and management of neurosarcoidosis may benefit the patient and clinician faced with this multifaceted disease.

© 2014 American Academy of Neurology


Article Tools


Article Level Metrics

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.